Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

BACKGROUND: Bronchial asthma is a heterogeneous disease characterized by three cardinal features: chronic inflammation, variable airflow obstruction, and airway hyperresponsiveness. Asthma has traditionally been defined using nonspecific clinical and physiologic variables that encompass multiple phe...

詳細記述

保存先:
書誌詳細
出版年:Clin Transl Allergy
主要な著者: Riccio, Anna Maria, Mauri, Pierluigi, De Ferrari, Laura, Rossi, Rossana, Di Silvestre, Dario, Benazzi, Louise, Chiappori, Alessandra, Dal Negro, Roberto Walter, Micheletto, Claudio, Canonica, Giorgio Walter
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5345272/
https://ncbi.nlm.nih.gov/pubmed/28293414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-017-0143-1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料